Venous Leg Ulcer Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-01-13　·　152 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 2.62 Bn
2033 年預估規模: USD 6.64 Bn
年複合成長率 CAGR: 14.2%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-01-13頁數 152報告編號 CMI9208

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Venous Leg Ulcer Market, By Type of Ulcer (Primary Venous Ulcers and Secondary Venous Ulcers), By Treatment Type (Compression Therapy, Dressings and Bandages, Skin Grafts and Flaps, Medication and Topical Agents, Surgical Procedures, and Others),By End User (Hospitals, Specialty Clinics and Dermatology Centers, Home Care Settings, and Ambulatory Surgical Centers), By Disease Severity (Mild, Moderate, and Severe), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)

報告摘要

According to Coherent Market Insights, the global venous leg ulcer market is estimated to be valued at USD 2.62 Bn in 2026 and is expected to reach USD 6.64 Bn by 2033, expanding at a compound annual growth rate (CAGR) of 14.2% from 2026 to 2033. The global venous leg ulcer market represents a critical segment within the wound care and vascular therapeutics industry, addressing one of the most prevalent and challenging chronic wound conditions affecting millions of patients worldwide. Venous leg ulcers, which account for approximately 70-90% of all leg ulcers, occur as a result of chronic venous insufficiency, where damaged or weakened valves in the leg veins prevent proper blood circulation back to the heart, leading to venous hypertension, inflammation, and subsequent tissue breakdown. These chronic wounds significantly impact patient quality of life, often persisting for months or years without proper treatment, and impose substantial economic burden on healthcare systems globally. The market encompasses a comprehensive range of treatment modalities including compression therapy systems, advanced wound dressings, topical medications, surgical interventions, and emerging innovative therapies such as bioengineered skin substitutes and growth factor treatments. With an aging global population, increasing prevalence of diabetes, obesity, and vascular diseases, coupled with growing awareness about advanced wound care management, the venous leg ulcer market is experiencing significant growth momentum, driving continuous innovation in therapeutic approaches and creating substantial opportunities for healthcare providers, medical device manufacturers, and pharmaceutical companies to develop more effective, cost-efficient solutions for managing this complex chronic condition. Market Dynamics The global venous leg ulcer market is primarily driven by several interconnected factors that collectively fuel its expansion and evolution. The increasing prevalence of chronic venous insufficiency, particularly among the aging population, serves as the fundamental growth driver, as elderly individuals are more susceptible to venous disorders due to weakened vein walls and valve dysfunction. Rising incidence of diabetes mellitus, obesity, and cardiovascular diseases further amplifies the market demand, as these conditions significantly increase the risk of developing venous leg ulcers and complicate the healing process. Technological advancements in wound care management, including the development of sophisticated compression therapy systems, bioactive dressings, and regenerative medicine approaches, are revolutionizing treatment outcomes and driving market growth. However, the market faces notable restraints including high treatment costs, particularly for advanced therapies and long-term care management, which can limit patient access and healthcare system adoption. Limited awareness about proper wound care management among patients and healthcare providers in developing regions, coupled with inadequate healthcare infrastructure, poses significant challenges to market penetration. Additionally, the complex and chronic nature of venous leg ulcers often leads to treatment failures and recurrence, creating skepticism about therapeutic effectiveness. Despite these challenges, substantial opportunities emerge from the growing emphasis on preventive healthcare, increasing healthcare expenditure in emerging markets, and rising adoption of telemedicine and digital health solutions for remote wound monitoring. The development of personalized medicine approaches, integration of artificial intelligence in diagnosis and treatment planning, and expanding research into novel therapeutic targets present lucrative avenues for market expansion and innovation. Key Features of the Study • This report provides in-depth analysis of the global venous leg ulcer market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global venous leg ulcer market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Smith & Nephew, 3M, Mölnlycke Health Care, ConvaTec, Coloplast, URGO Medical, Paul Hartmann, Essity, B Braun, Bauerfeind, SIGVARIS GROUP, Organogenesis, MiMedx Group, Integra LifeSciences, and medi GmbH & Co KG. • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global venous leg ulcer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global venous leg ulcer market Market Segmentation • Type of Ulcer Insights (Revenue, USD Bn, 2021 - 2033) o Primary Venous Ulcers o Secondary Venous Ulcers • Treatment Type Insights (Revenue, USD Bn, 2021 - 2033) o Compression Therapy o Dressings and Bandages o Skin Grafts and Flaps o Medication and Topical Agents o Surgical Procedures o Others • End User Insights (Revenue, USD Bn, 2021 - 2033) o Hospitals o Specialty Clinics and Dermatology Centers o Home Care Settings o Ambulatory Surgical Centers • Disease Severity Insights (Revenue, USD Bn, 2021 - 2033) o Mild o Moderate o Severe • Regional Insights (Revenue, USD Bn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Smith & Nephew o 3M o Mölnlycke Health Care o ConvaTec o Coloplast o URGO Medical o Paul Hartmann o Essity o B Braun o Bauerfeind o SIGVARIS GROUP o Organogenesis o MiMedx Group o Integra LifeSciences o medi GmbH & Co KG

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Venous Leg Ulcer Market, By Type of Ulcer  Global Venous Leg Ulcer Market, By Treatment Type  Global Venous Leg Ulcer Market, By End User  Global Venous Leg Ulcer Market, By Disease Severity  Global Venous Leg Ulcer Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Key Developments o Industry Trends 4. Global Venous Leg Ulcer Market, By Type of Ulcer, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Primary Venous Ulcers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Secondary Venous Ulcers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 5. Global Venous Leg Ulcer Market, By Treatment Type, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Compression Therapy  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Dressings and Bandages  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Skin Grafts and Flaps  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Medication and Topical Agents  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Surgical Procedures  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 6. Global Venous Leg Ulcer Market, By End User, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Hospitals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Specialty Clinics and Dermatology Centers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Home Care Settings  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Ambulatory Surgical Centers  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 7. Global Venous Leg Ulcer Market, By Disease Severity, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Mild  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Moderate  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Severe  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 8. Global Venous Leg Ulcer Market, By Region, 2021 - 2033, Value (USD Bn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Type of Ulcer, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Disease Severity, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Type of Ulcer, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Disease Severity, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Type of Ulcer, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Disease Severity, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Type of Ulcer, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Disease Severity, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Type of Ulcer, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Disease Severity, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Type of Ulcer, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Treatment Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Disease Severity, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn) o South Africa o North Africa o Central Africa 9. Competitive Landscape o Smith & Nephew  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o 3M  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Mölnlycke Health Care  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o ConvaTec  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Coloplast  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o URGO Medical  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Paul Hartmann  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Essity  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o B Braun  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Bauerfeind  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o SIGVARIS GROUP  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Organogenesis  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o MiMedx Group  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Integra LifeSciences  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o medi GmbH & Co KG  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 10. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 11. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on ‘Venous Leg Ulcer Market' - Global forecast to 2033

提及公司

Smith & Nephew3MMölnlycke Health CareConvaTecColoplastURGO MedicalPaul HartmannEssityB BraunBauerfeindSIGVARIS GROUPOrganogenesisMiMedx GroupIntegra LifeSciencesmedi GmbH & Co KG

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們